Drug Shortage Report for JAMP-LOSARTAN HCTZ

Last updated on 2018-05-19 History
Report ID 23908
Drug Identification Number 02408244
Brand name JAMP-LOSARTAN HCTZ
Common or Proper name Losartan HCTZ
Company Name JAMP PHARMA CORPORATION
Market Status CANCELLED POST MARKET
Active Ingredient(s) HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-09-01
Estimated end date
Actual end date 2018-05-18
Shortage status Resolved
Updated date 2018-05-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2018-05-19 English Compare
v27 2018-05-18 French Compare
v26 2018-05-18 English Compare
v25 2018-05-18 French Compare
v24 2018-05-18 English Compare
v23 2018-05-01 French Compare
v22 2018-05-01 English Compare
v21 2018-04-16 French Compare
v20 2018-04-16 English Compare
v19 2018-03-29 French Compare
v18 2018-03-29 English Compare
v17 2018-03-09 French Compare
v16 2018-03-09 English Compare
v15 2018-01-09 French Compare
v14 2018-01-09 English Compare
v13 2017-12-22 French Compare
v12 2017-12-22 English Compare
v11 2017-12-11 French Compare
v10 2017-12-11 English Compare
v9 2017-12-04 French Compare

Showing 1 to 20 of 28